Collagen I alpha 1 telopeptide Antibody
ELISA, Immunohistochemistry, Immunoprecipitation, Western Blot
Rabbit
H. sapiens (Human); Mus musculus (Mouse); Sheep; Rat
IgG
Polyclonal
Anti-Collagen-1 alpha 1 telopeptide Antibody was produced in rabbit by repeated immunizations with a proprietary peptide immunogen corresponding to co
Alpha-1 type I collagen, COLA1A1


Collagen I alpha 1 telopeptide Antibody detects collagen I which is an extracellular matrix protein that serves as a scaffold defining the shape and mechanical properties of many tissues and organs including skin, tendon, artery walls, fibrocartilage, bone and teeth. Type 1 collagen is the most abundant protein in mammals. Collagens are synthesized with N-terminal and C-terminal propeptides that are cleaved during maturation and secretion. After cleavage of the propeptides, the most N-terminal and C-terminal remaining sequences are known as telopeptides. Mutations in the collagen 1, alpha 1 gene (COL1A1) are known to cause osteogenesis imperfecta (aka brittle bone disease) . Furthermore, mutations found in the first 90 residues of the helical region of alpha 1 collagen have been implicated in the prevention or delayed removal of the procollagen N-propeptide leading to a combined osteogenesis imperfecta and Ehlers-Danlos syndrome (EDS) phenotype. Anti-Collagen I alpha 1 telopeptide Antibody is ideal for investigators involved in Cell Signaling, Neuroscience, Signal Transduction research. Anti-Collagen 1 alpha 1 telopeptide Antibody is tested for use in ELISA, Western Blotting and IHC. The antibody works well for IHC on paraformaldehyde-fixed sections with a simple antigen-retrieval protocol (incubate slides for 20 minutes at 90º C in 10 mM sodium citrate (pH 6.0) / 0.1 % Tween-20) . Note that in paraffin sections of formaldehyde-fixed fibrotic mouse lung tissue, the antibody recognizes mature collagen I that has formed fibrils in the extracellular matrix. For Western blot with appropriately prepared samples expect a band of approximately 140 kDa in size corresponding to the telopeptide portion (C-terminus) of the collagen I alpha I polypeptide. Specific conditions for reactivity should be optimized by the end user.

